Amiodarone-induced thyrotoxicosis: Left ventricular dysfunction is associated with increased mortality

European Journal of Endocrinology

Volumn 154, Issue 4, 2006, Pages 533-536

  O'Sullivan, Anthony J ^a   Lewis, Mridula ^a   Diamond, Terrance ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CARBIMAZOLE; LIOTHYRONINE; PREDNISONE; RADIOACTIVE IODINE; THYROTROPIN; THYROXINE;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DOSE RESPONSE; DRUG INDUCED DISEASE; FEMALE; GRAVES DISEASE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HUMAN; INFORMATION PROCESSING; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLASMAPHERESIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THYROID SURGERY; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TOXIC GOITER;

ADULT; AGED; AMIODARONE; ARRHYTHMIA; FEMALE; GOITER, NODULAR; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROTOXICOSIS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33646067422     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02122     Document Type: Article

References (25)

1. Harjai KJ & Licata AA. Effects of amiodarone on thyroid function. Annals of Internal Medicine 1997 126 63-67.
2. Basaria S & Cooper DS. Amiodarone and the thyroid. American Journal of Medicine 2005 118 706-714.
3. Martino E, Bartalena L, Bogazzi F & Braverman LE. The effects of amiodarone on the thyroid. Endocrine Reviews 2001 22 240-254.
4. Campbell TJ. The place of amiodarone: an overview of the four recent large controlled trials. Australian and New Zealand Journal of Medicine 1997 27 582-590.
5. Roy D, Talajic M, Dorian P, Connelly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S & Thibault T. Amiodarone to prevent recurrence of atrial fibrillation. New England Journal of Medicine 2000 342 913-920.
6. Bouvy ML, Heerdink ER, Hoes AW & Leufkens HG. Amiodarone-induced thyroid dysfunction associated with cumulative dose. Pharmacoepidemiology and Drug Safety 2002 11 601-602.
7. Wong R, Cheung W, Stockigt JR & Topliss DJ. Heterogeneity of amiodarone-induced thyrotoxicosis: evaluation of colour-flow Doppler sonography in predicating therapeutic response. Internal Medicine Journal 2003 33 420-426.
8. Newnham HH, Topliss DJ, Le Grand BA, Chosich N, Harper RW & Stockigt JR. Amiodarone-induced hyperthyroidism: assessment of the predictive value of biochemical testing and response to combined therapy using propylthiouracil and potassium perchlorate. Australian and New Zealand Journal of Medicine 1988 18 37-43.
9. Diamond TH, Rajagopal R, Ganda K, Manoharan A & Luk A. Plasmapheresis as a potential treatment option for amiodarone-induced thyrotoxicosis. Internal Medicine Journal 2004 34 369-370.
10. Ligtenberg J, Tulleken J & Zijlstra J. Plasmapheresis in thyrotoxicosis. Annals of Internal Medicine 1999 131 71-72.
11. Gough IR & Gough J. Surgical management of amiodarone-associated thyrotoxicosis. Medical Journal of Australia 2002 176 128-129.
12. Bogazzi F, Miccoli P, Berti P, Cosci C, Brogioni S, Aghini-Lombardi F, Materazzi G, Bartalena L, Pinchera A, Braverman LE & Martino E. Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. Surgery 2002 132 1114-1117.
13. Hamoir E, Meurisse M, Defechereux T, Joris J, Vivario J & Hennen G. Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective? World Journal of Surgery 1998 22 537-543.
14. Claxton S, Sinha SN, Donovan S, Greenaway TM, Hoffman L, Loughhead M & Burgess JR. Refractory amiodarone associated thyrotoxicosis: an indication for thyroidectomy. Australian and New Zealand Journal of Surgery 2000 70 174-178.
15. Bogazzi F, Bartalena L, Cosci C, Brogioni S, Dell'Unto E, Grasso L, Aghini-Lombardi F, Rossi G, Pinchera A, Braverman LE & Martino E. Treatment of Type II Amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. Journal of Clinical Endocrinology and Metabolism 1999 88 1999-2002.
16. Bartalena L, Brogioni S, Grasso L, Bogazzi, Burelli A & Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. Journal of Clinical Endocrinology and Metabolism 1996 81 2930-2933.
17. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE & Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism 1994 78 423-427.
18. Reichert LJ & de Rooy HA. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. British Medical Journal 1989 298 1547-1548.
19. Lazarus JH. Hyperthyroidism. Lancet 1997 349 339-343.
20. Schiller NB & Foster E. Analysis of left ventricular function. British Heart Journal 1996 75 17-26.
21. Albert SG, Alves LE & Rose EP. Thyroid dysfunction during chronic amiodarone therapy. Journal of the American College of Cardiology 1987 9 175-183.
22. Harjai KJ & Licata AA. Amiodarone-induced hyperthyroidism: a case series and brief review of literature. Pacing and Clinical Electrophysiology 1996 19 1548-1554.
23. Ladeson PW. Thyrotoxicosis and the heart: something old and something new. Journal of Clinical Endocrinology and Metabolism 1993 77 332-333.
24. Daniels GH. Amiodarone-induced thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism 2001 86 3-8.
25. Osman F, Franklyn JA, Sheppard MC & Gammage MD. Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 2002 105 1275-1277.